Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Halocyclization. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112159375B details a catalyst-free aqueous halocyclization route for 2,3-dihydrofurans, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN113880901B reveals a metal-free asymmetric halocyclization route for high-purity nucleoside intermediates, offering significant cost reduction and supply chain reliability.